Lexaria Bioscience develops innovative drug delivery platforms including DehydraTECH™ for the delivery of lipophilic molecules. It increases bio-absorption; reduces time of onset; and can reduce drug costs for orally administered bioactives.
Lovelace Biomedical is a large, not-for-profit CRO with interests including respiratory, infectious diseases, gene therapy, neuroscience, alternative tobacco products and medical countermeasures. Respiratory expertise includes formulations for DPIs, MDIs and nebulisers.
LTS is a pharmaceutical technology company that develops and manufactures drug delivery systems such as transdermal patches, oral thin films and microarray patches. Its systems are applied in more than 20 marketed products targeting multiple disease indications.
The health business team at Lubrizol Life Science partners with customers to speed their innovative medical devices and pharma products to market. Its team provides high-quality polymers and excipients, along with state-of-the-art product design, development and manufacturing services.
Lucideon is a development and commercialisation company focusing on materials technologies and processes for mutliple industries. It has an extensive pharma offering including formulation development, E&L, powder processing, and its own controlled release drug delivery technology, iCRT.
Lux Research provides market intelligence, focusing on technology-driven innovation. Its areas of focus include materials, health, food & wellness, digital and energy. The materials and health areas include coverage of drug delivery related aspects.